The cost of illness associated with stepped care for obsessive-compulsive disorder

Journal of Obsessive-Compulsive and Related Disorders

Volumn 2, Issue 2, 2013, Pages 144-148

  Diefenbach, Gretchen J ^a,b   Tolin, David F ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost effectiveness; Cost of illness; Obsessive compulsive disorder; Personalized medicine; Stepped care

Indexed keywords

ABSENTEEISM; ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; EXPOSURE AND RESPONSE PREVENTION; FAMILY LIFE; FEMALE; FUNCTIONAL DISEASE; GUIDED SELF HELP; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF HELP; THERAPY DELAY; WORK DISABILITY;

EID: 84874577313     PISSN: 22113649     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocrd.2012.12.005     Document Type: Article

References (35)

1. Barkley R.A., Murphy K.R. Attention-deficit hyperactivity disorder: A clinical workbook 1998, Guilford Press, New York. 2nd ed.
2. Borkovec T.D., Nau S.D. Credibility of analogue therapy rationales. Journal of Behavior Therapy and Experimental Psychiatry 1972, 3:257-260.
3. Brown T.A., Di Nardo P.A., Lehman C.L., Campbell L.A. Reliability of DSM-IV anxiety and mood disorders: Implications for the classification of emotional disorders. Journal of Abnormal Psychology 2001, 110:49-58.
4. Bureau of Labor Statistics. (2009). Occupational empolyment and wages summary, 2008. Washington, DC: United States Department of Labor.
5. Dimeff L.A., Paves A.P., Skutch J.M., Woodcock E.A. Shifting paradigms in clinical psychology: How innovative technologies are shaping treatment delivery. The Oxford handbook of clinical psychology 2011, 618-648. Oxford University Press, New York. D.H. Barlow (Ed.).
6. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., Stoddart G.L. Methods for the economic evaluation of health care programmes 2005, Oxford University Press, New York. 3rd ed.
7. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV personality disorders, (SCID-II) 1997, American Psychiatric Press, Inc, Washington, DC.
8. Flessner C.A., Allgair A., Garcia A., Freeman J., Sapyta J., Frankin M.E., et al. The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder. Depression and Anxiety 2010, 27:365-371.
9. Foa E.B., Kozak M.J. Mastery of obsessive-compulsive disorder: A cognitive-behavioral approach (therapist guide) 1997, Oxford University Press, New York.
10. Foa E.B., Liebowitz M.R., Kozak M.J., Davies S., Campeas R., Franklin M.E., et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 2005, 162:151-161.
11. Foa E.B., Wilson R. Stop obsessing!: How to overcome your obsessions and compulsions 2001, Bantam Books, New York.
12. Gilliam C.M., Diefenbach G.J., Whiting S.E., Tolin D.F. Stepped care for obsessive-compulsive disorder: An open trial. Behaviour Research and Therapy 2010, 48:1144-1149.
13. Goisman R.M., Rogers M.P., Steketee G.S., Warshaw M.G., Cuneo P., Keller M.B. Utilization of behavioral methods in a multicenter anxiety disorders study. Journal of Clinical Psychiatry 1993, 54:213-218.
14. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Delgado P., Heninger G.R., et al. The Yale-Brown obsessive compulsive scale. II. Validity. Archives of General Psychiatry 1989, 46:1012-1016.
15. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Archives of General Psychiatry 1989, 46:1006-1011.
16. Guy W. Assessment manual for psychopharmacology 1976, U.S. Government Printing Office, Washington, DC.
17. Holdnack J. Wechsler test of adult reading manual 2001, The Psychological Corporation, San Antonio, TX.
18. Jacobson N.S., Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 1991, 59:12-19.
19. Kazdin A.E., Blase S.L. Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspectives on Psychological Science 2011, 6:21-37.
20. Keeley M.L., Storch E.A., Merlo L.J., Geffken G.R. Clinical predictors of response to cognitive-behavioral therapy for obsessive-compulsive disorder. Clinical Psychology Review 2008, 28:118-130.
21. Kessler R.C., Chiu W.T., Demler O., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62:617-627.
22. Kessler R.C., Frank R.G. The impact of psychiatric disorders on work loss days. Psychological Medicine 1997, 27:861-873.
23. Koran L.M., Hanna G.L., Hollander E., Nestadt G., Simpson H.B. Practice guideline for the treatment of patients with obsessive-compulsive disorder. American Journal of Psychiatry 2007, 164(Suppl. 7):5-53.
24. Lewis C., Pearce J., Bisson J.I. Efficacy, cost-effectiveness and acceptability of self-help interventions for anxiety disorders: Systematic review. British Journal of Psychiatry 2012, 200:15-21.
25. Lovibond S.H., Lovibond P.F. Manual for the depression anxiety stress scales 1995, The Psychology Foundation of Australia, Sydney.
26. March J.S., Frances A., Carpenter D., Kahn D.A. The expert consensus guideline series: Treatment of obsessive-compulsive disorder. Journal of Clinical Psychiatry 1997, 58(Suppl. 4):1-72.
27. Mark T.L., Gibson T.M., McGuigan K., Chu B.C. The effects of antidepressant step therapy protocols on pharmaceutical and medical utilization and expenditures. American Journal of Psychiatry 2010, 167:1202-1209.
28. Marques L., LeBlanc N.J., Weingarden H.M., Timpano K.R., Jenike M., Wilhelm S. Barriers to treatment and service utilization in an internet sample of individuals with obsessive-compulsive symptoms. Depression and Anxiety 2010, 27:470-475.
29. McConnaughy E.A., Prochaska J.O., Velicer W.F. Stages of change in psychotherapy: Measurement and sample profiles. Psychotherapy: Theory, Research, and Practice 1983, 20:368-375.
30. Moritz S., Kloss M., Jacobsen D., Fricke S., Cutler C., Brassen S., et al. Neurocognitive impairment does not predict treatment outcome in obsessive-compulsive disorder. Behaviour Research and Therapy 2005, 43:811-819.
31. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1996, Harvard University Press, Cambridge, MA. C.J. Murray, A.D. Lopez (Eds.).
32. Shoham V., Insel T.R. Rebooting for whom? Portfolios, technology, and personalized intervention. Perspectives in Psychological Science 2011, 6:478-482.
33. Tolin D.F., Diefenbach G.J., Gilliam C.M. Stepped care versus standard cognitive-behavioral therapy for obsessive-compulsive disorder: A preliminary study of efficacy and costs. Depression and Anxiety 2011, 28:314-323.
34. Tolin D.F., Diefenbach G.J., Maltby N., Hannan S.E. Stepped care for obsessive-compulsive disorder: A pilot study. Cognitive and Behavioral Practice 2005, 12:403-414.
35. Tolin D.F., Frost R.O., Steketee G. An open trial of cognitive-behavioral therapy for compulsive hoarding. Behaviour Research and Therapy 2007, 45:1461-1470.